Arcellx, Inc. (DELISTED) (ACLX:DL)
115.07
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
Arcellx Profit Margin (Quarterly) : -3.51K% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 27.44% |
| Eli Lilly & Co. | 37.36% |
| Merck & Co., Inc. | -26.19% |
| Bristol Myers Squibb Co. | 23.31% |
| BioMarin Pharmaceutical, Inc. | 13.55% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.33% |
| Return on Assets | -35.35% |
| Return on Invested Capital | -48.29% |
| Gross Profit Margin (Quarterly) | 0.79% |
| Operating Margin (Quarterly) | -3.85K% |
| Return on Net Operating Assets | -327.1% |